Suwon, South Korea

Joon Gyo Oh

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Huons Co., Ltd., Huons Meditech Co., Ltd., Sk Chemicals Co., Ltd.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joon Gyo Oh. Retrieved from https://idiyas.com/inventor/joon-gyo-oh-p45c9u4b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0



Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Joon Gyo Oh in Pharmaceutical Development

Introduction

Joon Gyo Oh, a distinguished inventor based in Suwon-si, South Korea, has made a significant impact in the pharmaceutical industry. His innovative approach addresses the challenges associated with the stability of pharmaceutical compositions, particularly those containing docetaxel. With one patent to his name, Oh exemplifies the spirit of innovation that drives advancements in medicine.

Latest Patents

Oh's patent titled "Stable Pharmaceutical Composition Containing Docetaxel and a Method of Manufacturing the Same" introduces a novel solution for enhancing the storage stability of docetaxel, an essential chemotherapeutic agent. The invention details a method for preparing an injectable pharmaceutical composition that combines docetaxel with cyclodextrin and water-soluble polymers such as hydroxypropyl methylcellulose, polyethylene glycol, or polyvinylpyrrolidone. This innovative formulation allows for improved stability compared to traditional methods, ensuring that patients receive effective treatments.

Career Highlights

Joon Gyo Oh currently works at Sk Chemicals Co., Ltd., a leading company in the development of pharmaceutical products. His dedication to research and innovation has positioned him as a valuable contributor to the team, furthering the company's mission to provide effective healthcare solutions.

Collaborations

Throughout his career, Oh has collaborated with notable colleagues, including Nam Ho Kim and Jin Young Lee. These partnerships have fostered a creative environment that nurtures innovative ideas and drives the advancement of pharmaceutical technologies.

Conclusion

Joon Gyo Oh's work represents a significant step forward in pharmaceutical innovation, particularly in the development of stable formulations for critical medications like docetaxel. His contributions will undoubtedly have a lasting impact on the field, improving treatment options for patients worldwide. As the landscape of pharmaceutical science continues to evolve, inventors like Oh will play a crucial role in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…